Humoral markers of inflammation and endothelial dysfunction in relation to adiposity and in vivo insulin action in Pima Indians (Q43907982)

27 November 2017

Humoral markers of inflammation and endothelial dysfunction in relation to adiposity and in vivo insulin action in Pima Indians (English)

1 reference

Coenraad Dirk Adriaan Stehouwer

27 November 2017

0 references

1 reference

1 reference

3

object named as

Coen D A Stehouwer

1 reference

27 November 2017

4

Casper G Schalkwijk

1 reference

27 November 2017

Pietro Antonio Tataranni

6

object named as

P Antonio Tataranni

1 reference

27 November 2017

Christian Weyer

1

1 reference

27 November 2017

John S Yudkin

2

1 reference

27 November 2017

Richard E Pratley

5

1 reference

27 November 2017

1 March 2002

1 reference

27 November 2017

1 reference

27 November 2017

161

1 reference

27 November 2017

233-242

1 reference

27 November 2017

1

1 reference

Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?

27 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900626-8

Body mass index, diabetes, and C-reactive protein among U.S. adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900626-8

C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900626-8

Associations of C-reactive protein with measures of obesity, insulin resistance, and subclinical atherosclerosis in healthy, middle-aged women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900626-8

Insulin action and insulinemia are closely related to the fasting complement C3, but not acylation stimulating protein concentration.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900626-8

Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900626-8

Interleukin-6 and the acute phase response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900626-8

Immunological mechanisms in atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900626-8

NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900626-8

Is type II diabetes mellitus a disease of the innate immune system?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900626-8

Insulin resistance and inflammation in an evolutionary perspective: the contribution of cytokine genotype/phenotype to thriftiness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900626-8

Adhesion molecules and inflammatory injury.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900626-8

Neovascular expression of E-selectin, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 in human atherosclerosis and their relation to intimal leukocyte content

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900626-8

Circulating adhesion molecules in disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900626-8

Tumor necrosis factor alpha inhibits signaling from the insulin receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900626-8

Elevated C-reactive protein levels and impaired endothelial vasoreactivity in patients with coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900626-8

Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900626-8

von Willebrand Factor, C-Reactive Protein, and 5-Year Mortality in Diabetic and Nondiabetic Subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900626-8

Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): a cohort study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900626-8

Increased levels of soluble vascular cell adhesion molecule 1 are associated with risk of cardiovascular mortality in type 2 diabetes: the Hoorn study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900626-8

Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900626-8

Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900626-8

Soluble vascular cell adhesion molecule-1 as a biohumoral correlate of atherosclerosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900626-8

Soluble intercellular adhesion molecule, vascular cell adhesion molecule, and impaired microvascular reactivity are early markers of vasculopathy in type 2 diabetic individuals without microalbuminuria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900626-8

The relationship between plasma glucose and insulin responses to oral glucose, LDL oxidation, and soluble intercellular adhesion molecule-1 in healthy volunteers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900626-8

Endothelial dysfunction: cause of the insulin resistance syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900626-8

Insulin sensitivity and haemostatic factors in men at high and low cardiovascular risk. The Risk Factor Intervention Study Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900626-8

Exaggerated early insulin release and insulin resistance in a diabetes-prone population: a metabolic comparison of Pima Indians and Caucasians

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900626-8

Coronary heart disease prevalence and its relation to risk factors in American Indians. The Strong Heart Study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900626-8

The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900626-8

A high fasting plasma insulin concentration predicts type 2 diabetes independent of insulin resistance: evidence for a pathogenic role of relative hyperinsulinemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900626-8

Plasma concentration of C-reactive protein is increased in type I diabetic patients without clinical macroangiopathy and correlates with markers of endothelial dysfunction: evidence for chronic inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900626-8

Role of group II secretory phospholipase A2 in atherosclerosis: 1. Increased atherogenesis and altered lipoproteins in transgenic mice expressing group IIa phospholipase A2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900626-8

Relationship of the white blood cell count to body fat: role of leptin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900626-8

High incidence and prevalence of rheumatoid arthritis in Pima Indians

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900626-8

Elevated levels of soluble E-selectin in patients with IDDM and NIDDM: relation to metabolic control

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900626-8

Effects of insulin on in vitro vascular cell adhesion molecule-1 expression and in vivo soluble VCAM-1 release.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900626-8

Endothelial dysfunction in men with small LDL particles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900626-8

Plasma and lipoprotein cholesterol and triglyceride concentrations in the Pima Indians: distributions differing from those of Caucasians

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900626-8

Low incidence of fatal coronary heart disease in Pima Indians despite high prevalence of non-insulin-dependent diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900626-8

Diabetic kidney disease in Pima Indians

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900626-8

Diabetes mellitus in the Pima Indians: incidence, risk factors and pathogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900626-8

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0021-9150(01)00626-8

1 reference

27 November 2017

1 reference